Notably, PKD1 mutations account for 85–90% of the cases and are associated with significantly more severe diseases, whereas 10–15% of ADPKD cases are attributed to mutations in PKD2, and those patients have a later onset of symptoms and a slower rate of progression to renal failure. Here, PKD2 is linked to autosomal dominant polycystic kidney disease.